Black Rock Inc. Annovis Bio, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Annovis Bio, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 100,709 shares of ANVS stock, worth $504,552. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100,709
Previous 97,629
3.15%
Holding current value
$504,552
Previous $1.16 Million
50.04%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ANVS
# of Institutions
46Shares Held
1.17MCall Options Held
229KPut Options Held
934K-
Vanguard Group Inc Valley Forge, PA380KShares$1.91 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il103KShares$514,4860.0% of portfolio
-
Geode Capital Management, LLC Boston, MA99.1KShares$496,5610.0% of portfolio
-
Group One Trading, L.P. Chicago, IL52.8KShares$264,3620.02% of portfolio
-
Quest Partners LLC New York, NY46KShares$230,4700.03% of portfolio
About Annovis Bio, Inc.
- Ticker ANVS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,163,920
- Market Cap $40.9M
- Description
- Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...